ARTICLE | Clinical News
Coley begins Phase I/II
April 17, 2000 7:00 AM UTC
Coley Pharmaceutical Group (Wellesley, Mass.) began the first of three Phase I/II trials of its CpG 7909 CpG DNA-based immune stimulant to treat cancer. The U.S. trial will treat 24 patients with rela...